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ABSTRACT: Arginine-rich peptides and small-molecule intercalating agents utilize distinct molecular mecha-
nisms for RNA recognition. Here, we combined these distinct bindingmodules in an effort to create conjugate
ligands with enhanced affinity and specificity using the bacteriophage λ N peptide-boxB interaction as a
model system.We first designed and synthesized a series of peptide-acridine conjugates using portions of the
RNA-binding domain of N protein (11- and 22- residue peptide segments) and then compared the binding
affinity, specificity, salt dependence, and structural properties of the RNA-peptide and RNA-peptide-
acridine conjugate complexes using steady-state fluorescence, CD spectroscopy, NMR, and native gel mobi-
lity shift assays (GMSAs). These analyses revealed that the full-length peptide-acridine conjugate displayed
substantially improved RNA binding affinity (∼80-fold; Kd ∼ 15 pM) relative to that of the peptide alone
(Kd ∼ 1.2 nM). In accordance, we also observed specificity enhancement (∼25-fold) as determined via com-
parison of the binding of the best conjugate to a cognate λ boxB RNA with that to a noncognate P22 RNA
hairpin (80-fold vs 3.2-fold enhancement). Furthermore, the observed binding enhancement was unique to the
full-length conjugate with a flexible linker, implying that the structural context of the acridine presentation
was critical. Taken together, our observations support the idea that peptide- and intercalation-based binding
can be combined to create a new class of high-affinity, high-specificity RNA-binding ligands.
The design of proteins and other ligands with the capacity to
recognize nucleotide sequences with high affinity and specificity
has been the subject of extensive research in recent years; for
example, designed novel zinc finger proteins (1-3) and poly-
amides (4-7) were found to target themajor andminor groove of
DNA, respectively. In comparison, RNA molecules often fold
into complex and unique three-dimensional shapes and perform
versatile functions in diverse biological processes, thus prompting
great interest in designing sequence- or structure-specific RNA-
binding molecules. Enhanced understanding of sequence-specific
RNA-binding molecules and the expanding structural databases
for RNA and RNA-protein complexes, together with the deve-
lopment of new synthetic tools, have provided new opportunities
for the design of peptide or small-molecule RNA binders.
One approach to achieving enhanced RNA binding is to com-
bine different bindingmodules for interaction sites that coexist in
a given RNA molecule. In principle, if two binding sites are in
the proximity of each other, a dimeric derivative ligand can bind
simultaneously to the two sites, resulting in a binding affinity
greater than that of eithermodule alone (8, 9). Furthermore, such
modular design of RNA-binding ligands has been successfully
developed as multivalent ligands for targeting triplet repeat RNAs
that are implicated in myotonic muscular dystrophy and shown
to inhibit the formation of RNA-protein complexes (10).
As proof of principle, recent studies have shown acridine deri-
vatives to be a useful intercalatingmodule (11-14). In a new class
of HIV-1 Tat1 antagonists, a Tat-TAR binding inhibitor con-
sisting of a substituted acridine andapolyaminemoietywas demon-
strated to inhibit Tat function (15). Specifically, the modular
design principle was based on the stacking ability of the aromatic
moiety of acridine and the contacts with the TAR RNA phos-
phate backbone by a polycationic anchor. The two modules are
linked by an aliphatic linker. Aside from the compound stacking
between two bases, direct hydrogen bond contacts with a G 3C
base pair were also involved.
Two other studies further illustrate the utility of acridine
modules in RNA binding. A series of cationic small molecules
were synthesized, and their abilities to bind defined RNA dup-
lexes with and without bulged bases were investigated (16, 17).
Complex stabilization and selectivity for an RNA duplex con-
taining a single bulged base over a normal RNA duplex have
been obtained with a ligand consisting of a chloroacridine
moiety covalently attached to 2,6-diaminopurine through an amino-
alkyl linker. It is believed that the chloroacridine moiety inter-
calates into the RNA duplex and the 2,6-diaminopurine interacts
with the bulged base. Another example of this type of binding
enhancement is illustrated by a neomycin-acridine conjugate,
synthesized by covalently linking neomycin B to 9-aminoacridine
via a short spacer, as a potent inhibitor ofRev-RREbinding (18).
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neomycin B and approaches that of the Rev peptide. These results
demonstrate that the combination of different binding modes
(e.g., ionic and intercalation) within one ligand is a powerful app-
roach to enhancing RNA binding.
Acridine conjugation has also been used in designing func-
tional molecules. For example, attachment of an acridine moiety
to a catalytic tripeptide produced aRNasemimic (19), and that to
a base linker construct generated abasic site recognition and clea-
vage functions (20). Acridine has also been used in conjunction
with an oligonucleotide to facilitate site-selective RNA hydro-
lysis (21), where acridine was hypothesized to push the bulged
base out of the helix and present a scission site.
In light of the versatile and modular functions of acridine, we
reasoned that the same principle may also apply to the N peptide-
boxB RNA complex system. Bacteriophage N proteins play an
essential role in transcriptional antitermination, which is critical
for phage development (22). The inhibition of transcription ter-
mination at both intrinsic and Rho-dependent terminators by
N proteins depends on recognition of a cis-acting RNA element
called Nut (N utilization) on the nascent phage transcript.
Together with four Escherichia coli host factors (NusA, NusB,
NusG, and ribosomal protein S10), N protein and Nut initiate
the formation of a ribonucleoprotein complex that converts the
RNA polymerase into a termination-resistant form (22, 23).
The Nut site consists of a 50-single-stranded RNA element
(boxA) and a 30 hairpin (boxB) (24, 25). The boxB from λ phage is
a 15-mer RNA stem-loop hairpin containing a purine-rich
pentaloop. The RNA-binding domain of the N protein consists
of an arginine-rich motif located at the N-terminus (26). The 22-
residue short peptide recognizes the cognate boxB RNA with
specificity and affinity similar to those of the intactNprotein (27).
Upon formation of the complex, four of the pentaloop nucleo-
tides adopt a canonicalGNRA tetraloop fold (28) with the fourth
adenine extruded (29, 30); the peptide forms a bent R-helix and
binds tightly to the major groove of the RNA (29-31).
The RNA-protein interface of the λN22-boxB complex is
dominated by electrostatic interactions and hydrophobic con-
tacts (29). The five arginines and two lysines of λN22 create a
positively charged surface on one face of theR-helix that interacts
with the negatively charged phosphodiester backbone of the
boxB RNA. Hydrophobic interactions are also important for
boxB recognition. Ala-3 and Trp-18 are involved in crucial
hydrophobic interactions. In addition, the roles of arginine and
lysine residues are not restricted to ionic interaction; some of the
aliphatic portions of these side chains also contact theRNAbases
or sugars.
Given the detailed characterization presented above, the λN22-
boxB complex is an ideal model system for testing new bind-
ing modes, e.g., intercalation. In this paper, we report the use of
acridine-peptide conjugates to enhance binding of boxB RNA
targets by the N peptide.
MATERIALS AND METHODS
Synthesis of Peptides andAcridine-Peptide Conjugates.
Crude peptides with or without linkers were constructed by
automated solid phase peptide synthesis using Fmoc-protected
monomers (ABI) on an Applied Biosystems 432A peptide syn-
thesizer. A series of full-length λN22 and truncated λN11 acridine-
peptide conjugates were manually synthesized on the resin
using the chemistry outlined in Scheme 1. Two types of flexible
linkers, a Gly-Gly linker and an ethylene glycol linker, were used.
Crude peptides and crude acridine-peptide conjugates were
deprotected and cleaved from the resin and purified by reverse-
phase HPLC on a C18 column. The purity of the products was
checked by analytical HPLC and their identity confirmed by
MALDI-TOFmass spectrometry.Concentrationsof peptide stocks
were determined by UV absorption at 280 nm for free peptides
containing either tryptophan or tyrosine, or at 412 and 434 nm
for acridine-peptide conjugates using extinction coefficients
(ε=1.32 104 cm-1 M-1 at 412 nm, and ε=1.12 104 cm-1
M-1 at 434 nm) determined for a water-soluble acridine deriva-
tive (3-acridin-9-ylaminopropanol) synthesized from 9-chloro-
acridine and 3-amino-1-propanol as described previously (18).
Synthesis of 2AP-Labeled RNA Oligomers. Crude RNA
oligomers with a fluorescent 2-aminopurine (2AP) label substi-
tuted for adenine at the second, third, and fourth base positions
of the pentaloop (denoted 2AP-2, 2AP-3, and 2AP-4, respec-
tively) were constructed by automated synthesis using 2-amino-
purine-TOM-CE phosphoramidite (Glen Research, Sterling, VA).
Oligomers were deprotected and purified by 20% urea-PAGE.
Purified oligomers were desalted on aNAP-25 column and quan-
tified by UV absorption at 260 nm.
Steady-State Fluorescence Measurements. Steady-state
fluorescencemeasurements were taken on a ShimadzuRF-5301PC
spectrofluorophotometer as described previously (27, 32). Aliquots
of concentrated stocks of the free peptide or acridine-peptide
conjugates were added stepwise to a stirred solution of 2AP-
containing RNA maintained at various temperatures under a
series of buffer conditions. The fluorescence signal of 2AP was
monitored at 370 nm with excitation at 310 nm. Dissociation
constants (Kd) were calculated for a one-step binding mechanism
by nonlinear least-squares regression using DynaFit (33), as pre-
viously reported (34).
Band Shift Analysis. Free boxB RNA or peptide-RNA
complexes were created in NMR buffer [50 mM NaCl, 10 mM
phosphate, and 0.5 mM EDTA (pH 6)] and diluted with TBE
buffer before being loaded onto a 20%nondenaturing PAGE gel
maintained at 10-15 C. Free RNA and complex bands were
visualized by UV.
Scheme 1: Synthesis and Quantification of Acridine-Peptide
Conjugates
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One-Dimensional (1D) NMR Spectroscopy. Unlabeled
15-mer boxB RNA [50-GCCCUGAAAAAGGGC-30 (bases in
the loop are underlined)] was synthesized by in vitro transcription
using T7 RNA polymerase (35). The RNA was purified by 20%
urea-PAGE and desalted on a NAP-25 column. Purified RNA
oligomer was resuspended inNMRbuffer [50mMNaCl, 10mM
phosphate, and 0.5 mM EDTA (pH 6) in a 90:10 H2O/D2O
mixture]. Spectra were recorded on a Varian INOVA 600 MHz
NMR spectrometer at 25 C. The spectrum of free boxB RNA
was recorded first; titrationof the concentratedpeptide or acridine-
peptide conjugate into the boxB RNA was monitored by inspec-
tion of the imino proton region of RNA.
CD Spectroscopy. Spectra were recorded on an Aviv 62 DS
CD spectrometer at 20 C. The samples contained 5 μM RNA
and 6 μMpeptide in 10 mMpotassium phosphate buffer (pH 7.9).
The spectra of the bound peptides were determined via subtrac-
tion of the spectra for free RNAand excess free peptide from that
of the complex.
RESULTS
In the acridine-peptide conjugate-RNA complex, the high-
affinity λN peptide is expected to bind to the major groove of the
boxB RNA with the same molecular interactions as in the wild-
type complex (29, 30). Consequently, the acridine moiety may be
positioned proximal to the lower part of the RNA stem where it
can either intercalate into the stem (Figure 1) or simply associate
with the RNA extrahelically.
Kd Values. Dissociation constants (Kd) were determined by
monitoring the change in the fluorescence of 2-aminopurine (2AP)
incorporated at variable positions within the loops of the RNA
hairpins. This base was found to be an extremely useful probe for
nucleic acid structure and dynamics (36), as well as RNA-peptide
interactions (32). The fluorescence intensity of 2AP is highly
sensitive to the local environment, exhibiting a decrease or inc-
rease when stacked or solvent-exposed, respectively (37). In most
cases, peptide binding of the RNA can be detected by either
a fluorescence increase or decrease of more than 20% from the
starting value for the free boxB RNA (27, 38).
Table 1 lists the Kd values directly determined at 50 mM K
þ
and 20 mM Tris for acridine-λN11 and acridine-λN22 peptide
conjugates, compared to those of WT peptides alone, for boxB
RNA targets from both the λ and P22 phages. Binding affinities
for truncated λN11 peptide-acridine conjugates constructed with
either a Gly-Gly linker 1 or an ethylene glycol linker 2 were
similar and slightly weaker than those of the WT λN11 peptide.
However, the binding affinities were enhanced when the longer
andmore flexible linker 2was used on the full-length peptide. The
enhancement was dependent on the actual construct and RNA
targets, and the conjugates displayed increased binding specifi-
city. For example, an acridine-full-length peptide conjugate
showed an affinity of 0.015 nM for the 17mer boxB RNA with
2AP-4 labeling when extrapolated from a high-salt measurement
to 50mMKþ (Table 2 andFigure 2), corresponding to an 80-fold
enhancement over that of thewild-type full-length peptide (1.2 nM).
The longer and more flexible linker 2 seemed to confer affinity
enhancement. Full-length acridine peptide conjugates construc-
ted with the shorter and more rigid linker 1 exhibited less binding
enhancement; therefore, further investigations were focused on
linker 2. In line with this view, we also observed specificity enhan-
cement (∼25-fold) determined via comparison of the enhanced
binding affinity of the acridine-linker 2-λN22 peptide conjugate
to a cognate λ boxB RNA (80-fold) with a modest enhancement
(3.2-fold by comparing 257 nMwith 80 nM) to a noncognate P22
RNA hairpin.
Salt Dependence of Binding. In general, protein-nucleic
acid interactions become weaker with an increasing salt concen-
tration due to the electrostatic nature of binding. This principle
likely also applies to our system. Since the N peptide is arginine-
rich, the electrostatic interactions between positively charged
peptide side chains and the negatively charged RNA phosphate
backbone are critical for binding (29). Consequently, these electro-
static interactions aremitigated by an increasing concentration of
salt. Within a range of cation concentrations, plots of log(Kd)
versus log[Mþ] give a linear relationship. The slope of these plots
corresponds to the number of counterions that are released upon
peptide binding. In general, the slope is related to the net charge
of the peptide and ranges from 2.5 to 5 for theN peptide sequences
FIGURE 1: Design of the acridine-peptide conjugate binding to boxBRNA. Shown in themiddle is theNMRstructure (ProteinDataBank entry
1QFQ) of the boxBRNA-N peptide complex drawn with Pymol. The coordinates of the acridine moiety were modeled around the stem region
for schematic purposes. (A) Sequences and secondary stem-loop structures of boxBRNAfromλbacteriophages used in this study. (B) Sequences
of λN22 full-length and truncated λN11 peptides. The 11-mer was tagged with gy for quantification purposes. (C) Structure of acridine. (D) Struc-
tures of linkers.
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that have been tested (34). Representative salt-dependent curves
of dissociation constants for the acridine-full-length N peptide
conjugate-boxB RNA complex were shown using the 17-mer
RNA with 2AP-4 labeling (Table 2 and Figure 2). Most of the
isothermal curves showed biphasic transitions, with the second
transition starting after the peptide conjugate reaches a 1:1
stoichiometry with the RNA target. The Kd values were fit to
the first transition. Indeed, a higher salt concentration decreased
the binding affinity of acridine-peptide conjugate for boxB
RNA as observed for the WT peptide. The salt dependence
graph shows the linear relationship at higher salt concentrations
(Figure 2) as observed previously (39, 40). The derived slope
value of 2.9 was slightly higher than the value of 2.4 for the
wild-typeNpeptide, indicating roughly three cationswere released
upon binding. The Kd value extrapolated by the salt dependence
curve to 50 mM Kþ and 20 mM Tris was 0.015 nM. A roughly
80-fold binding enhancementwas observed across a broad range of
ionic concentrations. Since the conjugate showed a slightly higher
slope of salt dependence than the free peptide, the enhancement
was even higher when extrapolated to lower salt concentrations.
CD Spectra. The CD spectra recorded for boxB RNA bind-
ing by the acridine-linker 2-λN22 peptide conjugate and free full-
length λN22 peptide are shown in Figure 3. Neither the peptide nor
the acridine-peptide conjugate showed any appreciable structure
in the absence ofRNA.Thedifference spectra of the two complexes
indicated that both peptides folded into R-helices when bound to
the RNA. Although globally similar, the two complexes displayed
specific differences in regions indicative of peptide folding
(200-225 nm) and RNA folding (260-300 nm). The acridine
conjugate-RNA complex appeared to be less R-helical.
NMR Spectroscopy. NMR experiments can provide useful
structural information about the boxB RNA and the N peptide,
especially the structural change upon formation of the complex.
In particular, imino protons from RNA base pairs in the stem and
the Trp18 indole NH proton produce unique and easily detect-
able signals that are easy tomonitor.NMRspectrawere recorded
to distinguish theboxBRNAbindingbetween the acridine-peptide
conjugate and the free peptide (Figure 4).
The free 15-mer boxB RNA (Figure 4A, a) has 5 bp in the
stem. The 1D imino proton NMR spectrum showed three peaks
(13.25, 12.65, and 12.55 ppm) corresponding to the imino protons
of G12, G13, and G14 from the three middle CG base pairs. The
terminal GC pair was not observable due to fraying, and the U
Table 1: Dissociation Constants (Kd) for Peptides and Acridine-Peptide
Conjugates against boxBR RNA
a
aBinding constants were determined for the standard condition: 20 C,
50 mM KOAc, 20 mM Tris-OAc, pH 7.5. Individual isotherms were fit to a
one-step reaction with an error of <10%. Hairpin base positions substituted
with 2AP are underlined. Acr refers to the acridine moiety. bExtrapolated
from the high-salt measurement to 50 mM Kþ (see Table 2 and Figure 2).
Table 2: Salt Dependencea
aThe total monovalent cation concentration is the sum of Kþ and Tris.
Binding constants were determined for the standard condition: 20 C,
50-600mMKOAc, 20mMTris-OAc, pH 7.5. Individual isothermswere fit
to a one-step reaction with an error of <10%. Hairpin base positions
substituted with 2AP are underlined. Acr refers to the acridine moiety.
FIGURE 2: Saltdependenceof theλ full-lengthpeptide (9) andacridine-
full-length peptide conjugate (2) binding to 17-mer λ boxB RNA
(2AP-4). Measurements were taken at 20 C.
FIGURE 3: Comparison of CD spectra of free peptides and peptide-
boxB RNA complexes.
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imino proton from the loop closing UA pair was also missing,
presumably because of the flexibility of the unstructured penta-
loop in the free RNA. Binding by either full-length N peptide or
truncated amino-terminal 11-mer induced similar RNA structu-
ral changes, evidenced by shifting of the three CG imino protons
to higher field (Figure 4A, b and e). Beside these changes, there
were additional imino protons at 13.5 ppm corresponding to U5
of theUApair and a broader peak at 10.7 ppm attributable to the
G6 imino proton from the sheared GA base pair characteristic of
the GNRA tetraloop type of folding. This indicates that the loop
has been stabilized by peptide binding. In addition, the Trp18
indole NH proton in the full-length peptide has a large shift from
10 ppm (Figure 4A, d) in the free peptide to 9.2 ppm in the
complex (Figure 4A, e), which is due to the stacking interaction
between Trp18 and the RNA loop (30).
In comparison, the spectrum for the acridine-linker 2-λN11
conjugatebound to theboxBRNA(Figure 4A, c) didnot showthese
characteristic signal changes as observed for the λN11 peptide-
RNA complex, except for the broadening of the three original
peaks. This indicated that the acridine-λN11 peptide conjugate
did not bind theRNA in the samemode as the λN11 peptide. Since
acridine compound 3-acridin-9-ylaminopropanol was found to
bind to the boxB RNAwith an affinity of∼15 μM, similar to the
affinity between the λN11 peptide and the boxBRNA, it is possible
that the two modules compete for the RNA binding site, and the
acridine moiety may associate with the RNA nonspecifically,
thus disrupting the specific complex structure between the λN11
peptide and the boxBRNA.The imino protons ofU5 andG6 are
therefore broadened because of the heterogeneity of the complex,
as observed in other cases (41).
The spectrum for the 1:1 acridine-linker 2-full-length peptide
conjugate-boxB RNA complex (Figure 4A, f) showed very
similar imino proton signals for the RNA component and the
characteristic Trp18 indole proton shift as seen in the spectrum
for the λN22 peptide complex. Within the acridine-full-length
peptide conjugate, the peptide portion appeared to bind theRNA
in the same mode as in the wild-type λN22 peptide-RNA com-
plex, thus delivering the acridinemoiety to the lower part of boxB
RNA stem.
Since the acridine-full-length peptide conjugate exhibited
biphasic binding to the boxB RNA, we further investigated the
potential second binding site on the boxB RNA for the conju-
gate. Overtitration of the conjugate produced a 2:1 ratio for the
conjugate-RNAcomplex. Comparison of the spectra for 1:1 and
2:1 complexes of both the WT peptide and the acridine-peptide
conjugate revealed interesting discrepancies (Figure 4B). The
imino protons for U5 moved further downfield, and G6 and
G14moved upfield; furthermore, there was an additional peak at
FIGURE 4: One-dimensional NMR spectra for the peptide, boxB RNA, and complexes. (A) Comparison of λN11 and λN22 peptide-boxB
complexes: (a) free 15-mer boxB RNA, (b) λN11 peptide-boxB complex, (c) acridine-λN11 peptide conjugate-boxB RNA complex, (d) λN22
peptide or acridine-λN22 peptide conjugate alone, (e) λN22 peptide-boxB RNA complex, and (f) acridine-λN22 peptide conjugate-boxB
complex. (B) Comparison of the 1:1 peptide-boxB complex and the 2:1 peptide-boxB complex: (a) 1:1 λN22 peptide-boxB complex, (b) 2:1 λN22
peptide-boxBcomplex, (c) 1:1 acridine-λN22 peptide conjugate-boxBRNAcomplex, and (d) 2:1 acridine-λN22 peptide conjugate-boxBRNA
complex. The asterisk indicates the additional peak.
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12.4 ppm. These features suggest a specific second binding site for
the acridine-peptide conjugate.
Band Shift Analysis. Observations from NMR experiments
were consistent with the band shift analysis shown in Figure 5. A
band shift was observed indicative of specific binding of the boxB
RNA by the λN11 peptide (lane 2 of Figure 5A). On the other
hand, the smear for the acridine-linker 2-λN11 peptide conju-
gate with the boxB RNA (lane 3 of Figure 5A) indicated non-
specific interaction, possibly random intercalation of acridine
either in the stem or in the loop region which competes with the
binding of the peptide portion.
The acridine-linker 2-λN22 full-length conjugate, however,
exhibited not only a 1:1 complex with the boxB RNA 15-mer
(lane 3 of Figure 5B) as in the peptide-RNA complex (lane 2 of
Figure 5B) but also a higher-stoichiometry complex as well. These
results, likely suggestive of a second binding site for the acridine-
λN22 peptide conjugate, may explain the profile of the fluorescence
titration curves, which sometimes show biphasic transitions with
the second transition apparently following equimolar titration.
DISCUSSION
To achieve higher RNA binding affinities, the design of a ligand
consisting of two moieties connected by a linker is a promising
approach (8, 9). Higher binding affinities could result from a
favorable entropic factor compared with the binding of the two
monomeric counterparts. Under certain conditions, the length
andnature of the linker are critical. Themolecule can be a dimeric
form of a known binder (42) or consist of two distinct moieties
that bind to RNA in different modes, e.g., groove binding and
intercalation (15-18). To apply this idea to the N peptide sys-
tem, we designed and synthesized a series of λN peptide-based
peptide-acridine conjugates. Their binding affinities for boxB
RNAs with stem-loop hairpin structures were determined by
steady-state fluorescence measurements.
Binding Affinity and Specificity Enhancement. Acridine
compound 3-acridin-9-ylaminopropanol binds the boxB RNA
with an affinity of 15 μM, potentially conferring significant enhan-
cementwhen linked to another bindingmodule. Froma comparison
of the salt dependence of binding, our acridine-linker 2-λN22
peptide conjugation showed 80-fold binding enhancement over a
broad range of salt concentrations. This result is similar to the
binding enhancement observed for a neo-acridine construct over
neomycin B alone binding to a RRE RNA (18). This observed
binding enhancement was unique to the full-length conjugate
with a more flexible ethylene glycol linker tested, implying that
the structural context of acridine presentation was critical. The
same construct showed only 3-fold tighter binding to a related
P22 boxBRNA target. Compared to λ boxB, P22RNAdisplays
a flipped orientation for one base pair in the stem and has a
cytidine in the loop instead of adenine (Table 1). Homologous
hydrophobic interactions occur between the boxB hairpin stem
and conserved alanine residues within the N peptide amino-
terminal module. Distinct hydrophobic interactions are in-
volved between the boxB hairpin loops and carboxy-terminal
modules of the N peptides. In λ, a tryptophan residue stacks on
the boxB loop; in P22, nonpolar alanine and isoleucine residues
interact with an extruded pyrimidine. In both phage λ and P22,
the bound pentaloops adopt stable GNRA tetraloop folds by
extruding either loop base 4 (4-out) in the λ complex or loop
base 3 (3-out) in the P22 complex. Both λN22 and P22N21 full-
length peptides discriminate strongly between their cognate
RNA hairpins and other boxB RNA targets (34, 38). Our
acridine-linker 2-λN22 peptide conjugate exhibited 25-fold
binding specificity enhancement between these two similar
RNA structures.
In contrast, the acridine-λN11 peptide conjugate displayed
3-fold weaker binding than the λN11 peptide alone. The NMR
and gel shift data showed that the conjugate did not form a
specific complex with the boxB RNA (Figures 4A and 5A),
presumably due to the fact that the nonspecific binding of the
acridine moiety to the boxB RNA showed an affinity similar to
that of the λN11 peptide. Therefore, the acridine moiety competed
with the peptidemoiety for RNAbinding sites. Alternatively, it is
also possible that in the acridine-λN11 conjugate, nonspecific
electrostatic attraction byArg residues in the peptide to the RNA
becomes important as the origin of the low binding affinity of
the acridine-λN11 conjugate. This result suggests that when a
ligand with multiple binding modules is designed, it is important
to avoid a nonspecific bindingmodule that can compete for bind-
ing to multiple sites intended for other modules. Furthermore, a
module with a higher affinity for one site will help anchor the
entire ligand. Taken together, our observations indicate that the
specific binding peptidemodule of the full-length acridine-peptide
conjugate exhibits a much higher affinity for the λboxB RNA,
FIGURE 5: Gel shift analysis of peptide-boxB RNA complexes for WT peptides and acridine-peptide conjugates. (A) λN11-RNA and
acridine-λN11-RNA complexes. (B) λN22-RNA and acridine-λN22-RNA complexes.
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thereby maintaining the native contacts with RNA (Figure 4A)
and facilitating delivery of the acridine moiety to the intended site.
Acridine Intercalating Site. Previous structural studies on
DNA intercalated with acridine-related compounds have con-
sistently shown intercalation sites at alternating base steps,
particularly at the terminal base steps (43). This is likely due to
the fact that terminal base steps have much greater conforma-
tional freedom than internal base steps and, thus, are more
receptive to intercalation. Recent studies on DACA, an anti-
tumor acridine derivatized with variable functional substitutions
at position 4, showed that they intercalate into DNA with side
chains positioned in the major groove (44-46). However, the
crystal structure of an acridine-tetraarginine conjugate with the
peptide attached to position 9 showed intercalation of acridine
into the minor groove of the central AA/TT base step of a long
DNA fragment, leaving the peptide in the minor groove (47).
In these cases, it appeared that specific hydrogen bonding
interactions between the lateral chain of acridine and DNA may
affect how the acridine moiety intercalates into nucleic acid.
Interestingly, a recent study also showed that in peptide-acridine
conjugates, the point of attachment on acridine affected the
conjugates’ affinity for the nucleic acid target (11).
Our acridine-N peptide conjugates feature attachment of
the peptide to acridine at position 9, similar to the acridine-
tetraarginine case. The mode of binding of acridine in these
conjugates is currently unknown. If the acridine moiety deriva-
tized at position 9 with a peptide prefers intercalation into the
minor groove as in the case of the acridine-tetraarginine com-
plex (47), our construct may preclude intercalation because the
full-lengthN peptide binds to the boxBRNA in themajor groove
with high affinity. With respect to the acridine-λN11 conjugate,
the acridine may be able to intercalate into the minor groove;
however, such intercalation is probably not site-specific. Alter-
natively, binding of the N peptide, especially the full-length
version, to the boxB RNA peptide may induce RNA folding.
There are extensive interactions between the peptide and the
RNA stem, some of which may be disrupted by an intercalated
acridine moiety in the stem. Although the acridine may still be
able to intercalate at the terminal base step, the inability to
directly observe the imino proton from the terminal base pair
precludes direct confirmation of this possibility.
ASecond Specific Binding Site for the Acridine-NPeptide
Conjugate on the boxB RNA. Similar to the neo-acridine case
(18) which involved a second binding site, our fluorescence,
NMR, and gel shift data also suggested a second specific binding
site for the acridine-Npeptide conjugate on the boxBRNA.The
nature of the second site is not known but may involve either the
major or the minor groove. Changes in the imino proton chemi-
cal shifts were observed throughout theRNAstructure (Figures 4B
and 5), suggesting extensive interactions.
Alternative approaches to enhancingRNAbinding affinity are
also available. N peptides bind to the boxB RNA in an R-helical
conformation but exhibit little helical structure when free in
solution (31). Stabilizing the helical form of such peptides is
expected to favor RNAbinding by virtue of preorganization. For
example, CR-substituted amino acids have long been recognized
as a means of introducing local conformational restriction into
peptides (48). Another approach to stabilize the R-helical form of
peptides is through the incorporation of covalent linkages bet-
ween constituent amino acid side chains. It was found that sub-
stantial helix stabilization was achieved when the linkage was
placed between residues i and i þ 4 in the peptide backbone by
ring closing metathesis (49-52). Therefore, cyclic helical N pep-
tides in which ring closing metathesis is used to incorporate a
carbon-carbon tether between appropriate residue side chains is
expected to enhance binding. In line with this view, our analyses
revealed that the full-length peptide-acridine conjugate had
substantially improved RNA binding affinity (∼80-fold) and
specificity (∼25-fold) relative to those of the peptide alone. Our
work supports the idea that peptide- and intercalation-based
binding can be combined to create a new class of high-affinity,
high-specificity RNA-binding ligands. This approach provides
straightforward optimization to enhance the affinity of known
modules and facilitate the discovery of powerful new hybrid
ligands with novel functionalities.
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